Article Information
History
- March 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Serre-Yu Wong1,#,
- Rebekah Dixon1,
- Vicky Martinez Pazos1,
- ICARUS-IBD Working Group,
- Sacha Gnjatic2,
- Jean-Frederic Colombel*,1 and
- Ken Cadwell*,3
- 1The Henry D. Janowitz Division of Gastroenterology, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York
- 2The Precision Immunology Institute, Tisch Cancer Institute, Division of Hematology/Oncology, Human Immune Monitoring Center, Icahn School of Medicine at Mount Sinai, New York, New York
- 3Skirball Institute of Biomolecular Medicine, Department of Microbiology, Division of Gastroenterology and Hepatology, Department of Medicine, New York University School of Medicine, New York, New York
- ↵#Corresponding author
Serre-Yu Wong, One Gustave L. Levy Place, Box 1069, New York, New York 10029, Serre-Yu.Wong{at}mountsinai.org, 212-241-3179
↵* These authors share co-senior authorship.
Posted March 20, 2021.
Serological response to COVID-19 vaccination in IBD patients receiving biologics
